image description
A pharmaceutical company has expressed interest in buying several acres of Site 9 in the William Stanley Industrial Park.

Site 9 has Another Interested Buyer

By Breanna SteeleiBerkshires Staff
Print Story | Email Story

PITTSFIELD, Mass. — The Pittsfield Economic Development Authority held its shortest meeting on Thursday.

In June, Pittsfield's Business Development Manager Michael Coakley said there was an interested buyer for a couple of acres on Site 9, a pharmaceutical research and development company.

Coakley said they have received a purchase and sale agreement but before signing, there have to be assurances that the company has the financial requirements to construct the building.

He was to have another meeting with the company to go over questions on the purchase and sale agreement, as well as environmental and legal questions. Coakley said the company is still very interested and is trying to raise funds for its project. 

Coakley also brought the board up to date on the street names suggested in June 2025 of Mill Town Way, Morningside Way and Innovation Place.

He said Milltown Way and Innovation Place are in the process of being accepted, and the city will take over those streets. They are working with Milltown to make sure they are OK with the process and if it has any questions.

In other news, an electric energy company is interested in leasing Site 7 for six months. This entity hopes to use it for storage of shipping containers, staging, and parking for crews installing smart meters throughout the city. The lease would be $3,100 monthly, but the board could not vote on Thursday as it did not have a quorum.


Tags: industrial park,   PEDA,   

If you would like to contribute information on this article, contact us at info@iberkshires.com.

Kratom Products Pulled From Pittsfield, Statewide Shelves

By Brittany PolitoiBerkshires.com Staff

PITTSFIELD, Mass.— The state has put an emergency yearlong order on kratom products, and Pittsfield is working with retailers to remove the product from shelves. 

Last week, Director of Public Health Andy Cambi delivered an update on the emergency order that went into effect on August 28.  Also known by its chemical name and marketed with the term "7-OH," Massachusetts temporarily designated kratom as a Schedule I drug, greatly restricting sales. 

The formerly unregulated product has resulted in emergency room visits, poison control calls, and deaths.  

"Dependency and the opioid-like withdrawal symptoms are the major key health concerns," Cambi explained. "Liver toxicity, seizures, just a greater overdose risk when combined with other substances, and then the main thing is that this is not regulated."

He said that throughout the years, retail shops have reached out to the Health Department looking for guidance on kratom products and were notified that it is unregulated. 

"And for the most part, when they hear that, they don't sell the product," he added. 

Kratom is a leafy plant native to Southeast Asia containing naturally occurring substances, including mitragynine and 7-hydroxymitragynine (7-OH).  It is marketed to relieve pain and can produce stimulating or sedating effects, depending on the amount taken and potency. Newer products contain highly concentrated or laboratory-modified compounds that can have significantly stronger opioid-like effects. 

Kratom products have been widely sold in smoke shops, convenience stores, and gas stations as powders, tablets, capsules, gummies, dissolvable strips, and in other forms.

View Full Story

More Pittsfield Stories